FAMOTIDINE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 15 adverse event reports in the FDA FAERS database where FAMOTIDINE was used for Psoriasis.
Most Reported Side Effects for FAMOTIDINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 1,656 | 19.8% | 13 | 173 |
| Off label use | 714 | 8.6% | 41 | 106 |
| Product use in unapproved indication | 553 | 6.6% | 7 | 23 |
| Nausea | 323 | 3.9% | 15 | 85 |
| Exposure during pregnancy | 317 | 3.8% | 0 | 38 |
| Diarrhoea | 315 | 3.8% | 18 | 81 |
| Dizziness | 310 | 3.7% | 4 | 42 |
| Therapeutic response unexpected | 287 | 3.4% | 0 | 4 |
| Fatigue | 241 | 2.9% | 20 | 54 |
| Headache | 233 | 2.8% | 0 | 42 |
| Vomiting | 225 | 2.7% | 16 | 87 |
| Anaphylactic reaction | 202 | 2.4% | 0 | 82 |
| Dyspnoea | 196 | 2.4% | 3 | 59 |
| Incorrect dose administered | 191 | 2.3% | 0 | 1 |
| Condition aggravated | 185 | 2.2% | 5 | 53 |
Other Indications for FAMOTIDINE
Product used for unknown indication (3,156)
Gastrooesophageal reflux disease (1,099)
Dyspepsia (1,003)
Premedication (181)
Prophylaxis (163)
Abdominal discomfort (104)
Urticaria (96)
Mast cell activation syndrome (90)
Nausea (85)
Gastric disorder (76)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)